Addition of Algenpantucel-L Immunotherapy to Standard Adjuvant Therapy for Pancreatic Cancer: A Phase 2 Study

Jeffrey M. Hardacre, Mary Mulcahy, William Small, Mark Talamonti, Jennifer Obel, Smitha Krishnamurthi, Caio S. Rocha-Lima, Howard Safran, Heinz Joseph Lenz, E. Gabriela Chiorean

Research output: Contribution to journalArticlepeer-review

120 Scopus citations

Fingerprint

Dive into the research topics of 'Addition of Algenpantucel-L Immunotherapy to Standard Adjuvant Therapy for Pancreatic Cancer: A Phase 2 Study'. Together they form a unique fingerprint.

Medicine & Life Sciences